活血化瘀药在脑出血急性期应用的临床研究-中医内科学专业论文.docxVIP

摘要 摘要 活血化瘀药在脑出血急性期应用的临床研究 活血化瘀药在脑出血急性期应用的临床研究 PAGE PAGE 13 PAGE PAGE 10 摘要 目的：通过观察疏血通注射液对脑出血急性期颅内血肿、脑水肿、神经功能评 分、血液流变学及安全性指标的影响，探讨疏血通注射液在脑出血急性期的治疗 作用及其安全性，为脑出血急性期应用活血化瘀药物治疗提供临床依据。 方法：将 46 例急性脑出血患者随机分为治疗组与对照组各 23 例，对照组给予 降颅压，减轻脑水肿、改善脑功能及相应对症支持疗法；治疗组在对照组用药基 础上加用疏血通注射液静注，每日一次，疗程均为 14 天；以治疗前后神经功能评 分、颅内血肿、脑水肿程度、血液流变学及心肝肾功能作为临床观察指标，并评 定其疗效及安全性。 结果：治疗 14 天后，两组临床观察各项指标均改善，治疗组神经功能学评分、 血肿脑水肿及血液流变学指标的改善，明显优于 对照组；治疗组安全性指标检测 未发现心、肝、肾功能异常。 结论：疏血通注射液在脑出血急性期能有效的促进血肿吸收，明显减少血肿周 围水肿，降低脑出血患者神经功能评分，改善临床症状，不会诱发再出血。 关键词：脑出血 急性期 疏血通注射液 活血化瘀疗法 Investigate 0f Acute Inebraltracer Hemorrhage with Activating Blood to Remove Blood Stasis Yao Xianli(Internal Medicine of Traditional Chinese Medicine) Directed by Gong Hongtao Abstract Objective: By observing Shuxuetong injection on acute cerebral hemorrhage intracranial hematoma, cerebral edema, neurological score, hemorheology and safety indicators, and to explore Shuxuetong injection in the treatment of acute cerebral hemorrhage and its security, for the acute phase of cerebral hemorrhage bloo d circulation to provide clinical basis for drug treatment. Methods: 46 patients with acute cerebral hemorrhage were randomly divided into treatment group and control group 23 patients in the control group was given lower intracranial pressure, cerebral edema, improve brain function and the corresponding symptomatic and supportive therapy; drug treatment group were based on the use Shu - xuetong intravenous injection once a day course of treatment was 14 days; for the trea - tment of neurological function after cerebral hematoma, edema, blood rheology and the heart, liver function as indicators of clinical observation, and to assess its efficacy and safety. Result: 14 days after treatment, clinical observation of two indicators are impr -oved,and the treated group neurological score, hematoma, cerebral edema and improved hemorheology, significantly better than control group; safety index analysis showed that the treated groups heart,liver kidney functi